Possibilities of low-dose radiation therapy in the treatment of intrapulmonary injuries caused by COVID-19 infection
https://doi.org/10.24835/1607-0763-991
Abstract
This paper examines the relevance of the use of a single irradiation of lungs in treatment of pneumonia caused by a new coronavirus infection. Clinical observations are presented that demonstrate perspectives in the treatment of this disease. Patients with severe pneumonia who were prescribed LD-RT (low-dose radiation therapy) at a dose of 0.5–1.5 Gy showed shorter recovery times and no complications. This method of treatment has shown its effectiveness in a number of studies from different countries, predicting success and economic benefits in its further use and study. A literature search containing information on relevant studies was carried out in PubMed, EMBASE, Web of Science and Google Scholar systems. Attention was focused on full-text articles given their general availability in a pandemic.
About the Authors
E. Y. Khomutova
Omsk State Medical University;
Omsk regional clinical hospital
Russian Federation
Russian Federation
Doct. of Sci. (Med.), Head of the department radiodiagnostics, 12, Lenina str., 644099, Omsk;
3, Berezovaya str., Omsk, 644099
P. V. Novikov
Omsk State Medical University;
Omsk regional clinical hospital
Russian Federation
Russian Federation
Cand. of Sci. (Med.), assistant of the department radiodiagnostics, 12, Lenina str., 644099, Omsk;
3, Berezovaya str., Omsk, 644099
A. S. Shatalov
Omsk State Medical University
Russian Federation
Russian Federation
resident of the department radiodiagnostics,
12, Lenina str., 644099, Omsk
References
1. Gorenkov D.V., Khantimirova L.M., Shevtsov V.A., Rukavishnikov A.V., Merkulov V.A., Olefir Yu.V. An Outbreak of a New Infectious Disease COVID-19: β-coronaviruses as a Threat to Global Healthcare. BIOpreparations. Prevention, Diagnosis, Treatment. 2020; 20 (1): 6–20. https://doi.org/10.30895/2221-996X-2020-20-1-6-20 (In Russian)
2. Pneumonia of unknown cause – China. Disease outbreak news. 5 January 2020. WHO [Electronic resource]. – 2020. – Available at: www.who.int/csr/don/05-january2020-pneumonia-of-unkown-cause-china/en/. – [Date of treatment: 14.10.2020].
3. Novel coronavirus – China. WHO [Electronic resource]. – 2020. – Available at: www.who.int/csr/don/12-january2020-novel-coronavirus-china/en/. – [Date of treatment: 14.10.2020].
4. Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. The epidemiological situation and the spread of COVID-19 in the world as of 08.00 (Moscow time) from 02.28.2020. [Electronic resource] – 2020. – Available at: rospotrebnadzor.ru/region/korono_virus/epid.php. – [Date of treatment: 05.01.2021] (In Russian)
5. Romanov B.K. Coronavirus Disease COVID-2019. Safety and Risk of Pharmacotherapy. 2020. 8 (1): 3–8. https://doi.org/10.30895/2312-7821-2020-8-1-3-8 (In Russian)
6. Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome. GenBank: MN908947.3 [Electronic resource]. – 2020. – Available at: www.ncbi.nlm.nih.gov/nuccore/MN908947.3. – [Date of treatment: 05.01.2021].
7. Kostinov M.P., Shmitko A.D., Polishchuk V.B., Khromova E.A. Modern representations of the new coronavirus and the disease caused by SARS-COV-2. Infectious Diseases: News, Opinions, Training. 2020; 9 (2): 33–42. (In Russian)
8. Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., Si H.-R., Zhu Y., Li B., Huang C.-L., Chen H.-D., Chen J., Luo Y., Guo H., Jiang R.-D., Liu M.-Q., Chen Y., Shen X.-R., Wang X., Zheng X.-S., Zhao K., Chen Q.-J., Deng F., Liu L.-L., Yan B., Zhan F.-X., Wang Y.-Y., Xiao G.-F., Shi Z.-L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579 (7798): 270–273. https://doi.org/10.1038/s41586-020-2012-7
9. Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., Bao L., Zhang B., Liu G., Wang Z., Chappell M., Liu Y., Zheng D., Leibbrandt A., Wada T., Slutsky A.S., Liu D., Qin C., Jiang C., Penninger J.M. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus – induced lung injury. Nature medicine. 2005; 11 (8): 875–879. https://doi.org/10.1038/nm1267
10. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., Farzan M. Angiotensinconverting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003; 426 (6965): 450–454.
11. Callaway E. The coronavirus is mutating-does it matter? Nature. 2020; 585 (7824): 174–177.
12. Isakov V. Prevention and therapy of coronavirus infection. Doctor. 2020; 31 (2): 72–74. (In Russian) https://doi.org/10.29296/25877305-2020-02-15
13. Kamkin E.G. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19): temporary methodical recommendations. Ministry of Health of Russian Federation. Moscow, 2020. 226 p. (In Russian)
14. World Health Organization. Regional office for Europe. [Electronic resource]. – 2020. – Available at: www.euro.who.int/ru/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/3/whoannounces-covid-19-outbreak-a-pandemic. – [Date of treatment: 05.01.2021].
15. N.A. Belyakov, V.V. Rassokhin, E.B.Yastrebova. Coronavirus infectious disease covid-19. Nature of virus, pathogenesis, clinical manifestations, report 1. HIV infection and immunosuppression. 2020; 12 (1): 7–21. https://doi.org/10.22328/2077-9828-2020-12-1-7-21 (In Russian)
16. Nikiforov V.V., Suranova T.G., Chernobrovkina T.Yu., Yankovskaya Y.D., Burova S.V. New Coronavirus Infection (Covid-19): Clinical and Epidemiological Aspects. The Russian Archives of Internal Medicine. 2020; 10 (2 (52)): 87–93. https://doi.org/10.20514/2226-6704-2020-10-2-87-93 (In Russian)
17. Nikiforov V.V., Suranova T.G., Mironov A.Yu., Zabozlaev F.G. New coronavirus infection (COVID-19): etiology, epidemiology, clinic, diagnosis, treatment and prevention. Moscow: FMBA Academy of Graduate Education, 2020. 48 с. (In Russian)
18. Wu Y. C., Chen C. S., Chan Y. J.The outbreak of COVID-19: An overview. J. Chinese Med. Assoc. 2020; 83 (3): 217.
19. Braciale T.J., Sun J., Kim T.S. Regulating the adaptive immune response to respiratory virus infection. Nat. Rev. Immunol. 2012; 12 (4): 295–305. https://doi.org/10.1038/nri3166
20. Hamada H., Bassity E., Flies A., Strutt T.M., GarciaHernandez M.de L., McKinstry K.K., Zou T., Swain S.L., Dutton R.W. Multiple redundant effector mechanisms of CD8+ T cells protect against influenza infection. J. Immunol. 2013; 190 (1): 296–306. https://doi.org/10.4049/jimmunol.1200571
21. Zhou Y., Fu B., Zheng X., Wang D., Zhao C., Qi Y., Sun R., Tian Z., Xu X., Wei H. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Nat. Sci. Rev. 2020; 7: 998–1002. https://doi.org/10.1093/nsr/nwaa041
22. Tiuliandina E.V., Piskov D.A. Cytokine-release syndrome: pathogenesis features, the role in the development of viral infection. A literature review. Sustainable development of science and education. 2019; 1: 256–260. (In Russian)
23. Shipilov M.V. “Cytokine storm” of the influenza: prospects for diagnosis. Ural Medical Journal. 2011; 7: 67–71. (In Russian)
24. Ye Q., Wang B., Mao J. Cytokine storm in COVID-19 and treatment. J. Infection. 2020; 80: 607–613. https://doi.org/10.1016/j.jinf.2020.03.037
25. Sequeira J.H. et al. A discussion on radiography, “X”-Ray treatment, the high-frequency method, and light treatment. Br. Med. J. 1902; 2 (2182): 1316–1319.
26. Russell E.J. The effect of radium on the growth of plants. Nature. 1915; 96 (2397): 147–148.
27. Kuzin A.M. Leading mechanisms of radiation hormesis. Bulletin of the Russian Academy of Sciences. Biology series. 1993; 6 (34): 824–832. (In Russian)
28. Kuzin A.M. The ideas of radiation hormesis in the atomic age. Moscow: The science, 1995. 156 с. (In Russian)
29. Ivanovsky Yu.A. Radiation hormesis. Is low-dose ionizing irradiation favorable? Far Eastern National University, Vladivostok. 2006; 6: 86–90. (In Russian)
30. Calabrese E.J., Dhawan G. How radiotherapy was historically used to treat pneumonia: could it be useful today? Yale J. Biol. Med. 2013; 86 (4): 555–570.
31. Kirkby C., Mackenzie M. Is low dose radiation therapy a potential treatment for COVID-19 pneumonia? Radiother. Oncol. 2020; 147: 221. https://doi.org/10.1016/j.radonc.2020.04.004
32. Wilson G.D., Mehta M.P., Welsh J.S., Chakravarti A., Rogers C.L., Fontanesi J. Investigating low-dose thoracic radiation as a treatment for COVID-19 patients to prevent respiratory failure. Radiat. Res. 2020; 194 (1): 1–8. https://doi.org/10.1667/RADE-20-00108.1
33. Dhawan G., Kapoor R., Dhawan R., Singh R., Monga B., Giordano J., Calabrese E.J. Low dose radiation therapy as a potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS). Radiother. Oncol. 2020; 147: 212–216. https://doi.org/10.1016/j.radonc.2020.05.002.
34. Dubin I.N., Baylin G.J., Gobble J.W.G. The effect of roentgen therapy on experimental virus pneumonia; on pneumonia produced in white mice by swine influenza. Am. J. Roentgenol. Radium Ther. 1946; 55: 478–481.
35. Hess C.B., Buchwald Z.S., Stokes W., Nasti T.H., Switchenko J.M., Weinberg B.D., Rouphael N., Steinberg J.P., Godette K.D., Murphy D., Ahmed R., Curran W.J. Jr, Khan M.K. Low-dose whole-lung radiation for COVID-19 pneumonia. medRxiv. 2020. Available at: https://doi.org/10.1101/2020.07.11.20147793. [Date of treatment: 05.01.2021].
36. Hess C.B. et al. Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 (RESCUE 1-19): A Randomized Phase III Trial of Best Supportive Care versus Whole Lung Low-Dose Radiation Therapy in Hospitalized Patients with COVID-19 [Electronic resource]. Emory Winship Cancer Institute. – 2020. – Available at: www.clinicaltrials.gov/ProvidedDocs/91/NCT04366791/Prot_SAP_000.pdf. – [Date of treatment: 05.01.2021].
37. Ameri А. et al. Low-dose whole-lung irradiation for COVID-19 pneumonia: short course results [Electronic resource]. International Journal of Radiation Oncology, Biology, Physics. – 2020. – Available at: doi.org/10.1016/j.ijrobp.2020.07.026. – [Date of treatment: 05.01.2021].
38. Castillo R. et al. Low-dose radiotherapy for COVID-19 pneumonia treatment: case report, procedure, and literature review [Electronic resource]. Strahlentherapie und Onkologie. – 2020. – Available at: doi.org/10.1007/s00066-020-01675-z. – [Date of treatment: 05.01.2021].
39. Kirsch D.G., Diehn M., Cucinotta F.A., Weichselbaum R. Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable. Radiother. Oncol. 2020; 147: 217–220.
Review
For citations:
Khomutova E.Y., Novikov P.V., Shatalov A.S. Possibilities of low-dose radiation therapy in the treatment of intrapulmonary injuries caused by COVID-19 infection. Medical Visualization. 2021;25(1):27-34. (In Russ.) https://doi.org/10.24835/1607-0763-991
Views:
753
Email this article 